Coping Strategies and Interpersonal Support in Patients With Irritable Bowel Syndrome and Inflammatory Bowel Disease  Michael P. Jones, Sarah Wessinger,

Slides:



Advertisements
Similar presentations
Irritable Bowel Syndrome and Microscopic Colitis: A Systematic Review and Meta- analysis Eline J.C.A. Kamp, John S. Kane, Alexander C. Ford Clinical Gastroenterology.
Advertisements

Celiac Disease Genetics: Current Concepts and Practical Applications Ludvig M. Sollid, Benedicte A. Lie Clinical Gastroenterology and Hepatology Volume.
Long-term Follow-up Reveals Low Incidence of Colorectal Cancer, but Frequent Need for Resection, Among Australian Patients With Inflammatory Bowel Disease.
MiraLAX Is Not as Effective as GoLytely in Bowel Cleansing Before Screening Colonoscopies Michael Hjelkrem, Joel Stengel, Mark Liu, David P. Jones, Stephen.
Risk of Neoplasia After Colectomy in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis Lauranne A.A.P. Derikx, Loes H.C.
Systematic Review of the Quality of Patient Information on the Internet Regarding Inflammatory Bowel Disease Treatments  Morgan Langille, André Bernard,
Abnormal Liver Tests and Fatty Liver on Ultrasound
Ashwin N. Ananthakrishnan, Millie D. Long, Christopher F
Noncardiac Chest Pain Clinical Gastroenterology and Hepatology
Prevalence, Characteristics, and Impact of Bloating Symptoms in Patients With Irritable Bowel Syndrome  Yehuda Ringel, Rachel E. Williams, Linda Kalilani,
Charles D. Gerson, Mary-Joan Gerson 
Diagnosis of irritable bowel syndrome
Diagnosis of celiac sprue
The Manitoba Inflammatory Bowel Disease Cohort Study: Prolonged Symptoms Before Diagnosis—How Much Is Irritable Bowel Syndrome?  Twila Burgmann, Ian Clara,
Factors Associated With Response to Placebo in Patients With Irritable Bowel Syndrome and Constipation  Sarah Ballou, Alissa Beath, Ted J. Kaptchuk, William.
Systematic review of the comorbidity of irritable bowel syndrome with other disorders: What are the causes and implications?  William E. Whitehead, Olafur.
Treatment of Esophageal (Noncardiac) Chest Pain: An Expert Review
Shou–Jiang Tang, Feriyl Bhaijee 
Gauree Gupta, Ebbing Lautenbach, James D. Lewis 
Immune Reconstitution Inflammatory Syndrome of the Small Bowel in a Human Immunodeficiency Virus–Negative Patient  Severin Daum, Christoph Loddenkemper,
Prevalence of Irritable Bowel Syndrome–type Symptoms in Patients With Celiac Disease: A Meta-analysis  Anita Sainsbury, David S. Sanders, Alexander C.
Trends in Overall and Cause-Specific Mortality Among Patients With Inflammatory Bowel Disease From 1982 to 2010  Tine Jess, Morten Frisch, Jacob Simonsen 
A Diet Low in Fermentable Oligo-, Di-, and Monosaccharides and Polyols Improves Quality of Life and Reduces Activity Impairment in Patients With Irritable.
Stephen A. Harrison, MD, FACP  Clinical Gastroenterology and Hepatology 
Negative Effects on Psychological Health and Quality of Life of Genuine Irritable Bowel Syndrome–type Symptoms in Patients With Inflammatory Bowel Disease 
Short-Bowel Syndrome Clinical Gastroenterology and Hepatology
Partner Burden in Irritable Bowel Syndrome
Andree Koop, Michael J. Bartel, Dawn Francis 
Genetics of Colonic Polyposis
Clinical Features, Treatment, and Survival of Patients With Colorectal Cancer With or Without Inflammatory Bowel Disease  Raja Affendi Raja Ali, Cara.
Jessica L. Mellinger, Michael L. Volk 
Translating Improved Quality of Care Into an Improved Quality of Life for Patients With Inflammatory Bowel Disease  Corey A. Siegel, John I. Allen, Gil.
Functional Dyspepsia Is Associated With Sleep Disorders
Systematic Review of the Quality of Patient Information on the Internet Regarding Inflammatory Bowel Disease Treatments  Morgan Langille, André Bernard,
Issue Highlights Clinical Gastroenterology and Hepatology
Spencer D. Dorn, Carolyn B. Morris, Susan E. Schneck, Teresa M
Michael Hjelkrem, Joel Stengel, Mark Liu, David P. Jones, Stephen A
Traveling Internationally: Avoiding and Treating Travelers' Diarrhea
AGA Clinical Practice Update on Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: Expert Review  Jean-Frederic Colombel,
David J. Hass, Colleen M. Brensinger, James D. Lewis, Gary R
Eluxadoline Demonstrates a Lack of Abuse Potential in Phase 2 and 3 Studies of Patients With Irritable Bowel Syndrome With Diarrhea  Reginald V. Fant,
Millie D. Long, Hans H. Herfarth, Clare A. Pipkin, Carol Q
Leon P. McLean, Jonathan S. Chun, Raymond K. Cross 
A Comprehensive Self-Management Irritable Bowel Syndrome Program Produces Sustainable Changes in Behavior After 1 Year  Jasmine K. Zia, Pamela Barney,
Severe Constipation Clinical Gastroenterology and Hepatology
Abnormal Liver Tests and Fatty Liver on Ultrasound
Reenu Malhotra, Kevin Turner, Amnon Sonnenberg, Robert M. Genta 
Kara Bradford, Wendy Shih, Elizabeth J. Videlock, Angela P
Peter Bytzer  Clinical Gastroenterology and Hepatology 
Rebecca M. Lovell, Alexander C. Ford 
Primary Sclerosing Cholangitis and Disease Distribution in Inflammatory Bowel Disease  Aoibhlinn O'Toole, Alaa Alakkari, Denise Keegan, Glen Doherty, Hugh.
Kavita Patel, Elise Presser, Meaghan George, Mark McClellan 
Effects of Different Coping Strategies on Physical and Mental Health of Patients With Irritable Bowel Syndrome  Lilian Dindo, PhD  Clinical Gastroenterology.
Risk of Cerebrovascular Accidents and Ischemic Heart Disease in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis  Siddharth.
Rectal Mucosal Nitric Oxide in Differentiation of Inflammatory Bowel Disease and Irritable Bowel Syndrome  Claudia I. Reinders, Max Herulf, Tryggve Ljung,
Risk of Cancer in Patients With Inflammatory Bowel Diseases: A Nationwide Population- based Cohort Study With 30 Years of Follow-up Evaluation  Michael.
Correlation Between the Crohn's Disease Activity and Harvey–Bradshaw Indices in Assessing Crohn's Disease Severity  Severine Vermeire, Stefan Schreiber,
Risk of Irritable Bowel Syndrome After an Episode of Bacterial Gastroenteritis in General Practice: Influence of Comorbidities  Ana Ruigómez, Luis Alberto.
Chronic Diarrhea Clinical Gastroenterology and Hepatology
Nicolas Williet, William J. Sandborn, Laurent Peyrin–Biroulet 
Meenakshi Bewtra, Chinyu Su, James D. Lewis 
Severe irritable bowel and functional abdominal pain syndromes: Managing the patient and health care costs  George F. Longstreth, Douglas A. Drossman 
Incidence of Neoplasms in Patients Who Develop Sustained Leukopenia During or After Treatment With 6-Mercaptopurine for Inflammatory Bowel Disease  William.
Issue Highlights Clinical Gastroenterology and Hepatology
Stability of Human Methanogenic Flora Over 35 Years and a Review of Insights Obtained From Breath Methane Measurements  Michael D. Levitt, Julie K. Furne,
David S. Fefferman, Richard J. Farrell 
Medical Therapy for Refractory Pediatric Crohn’s Disease
Issue Highlights Clinical Gastroenterology and Hepatology
Self-Administered Cognitive Behavior Therapy for Moderate to Severe Irritable Bowel Syndrome: Clinical Efficacy, Tolerability, Feasibility  Jeffrey M.
Jordan E. Axelrad, Sharyle A. Fowler, Sonia Friedman, Ashwin N
Presentation transcript:

Coping Strategies and Interpersonal Support in Patients With Irritable Bowel Syndrome and Inflammatory Bowel Disease  Michael P. Jones, Sarah Wessinger, Michael D. Crowell  Clinical Gastroenterology and Hepatology  Volume 4, Issue 4, Pages 474-481 (April 2006) DOI: 10.1016/j.cgh.2005.12.012 Copyright © 2006 American Gastroenterological Association Terms and Conditions

Figure 1 Correlation of scores on the IBDQ and IBS-QOL for patients with IBD. Scores on these QOL measures were correlated highly and the slope of the regression equation approached unity, supporting their comparability in assessing QOL in IBD. Clinical Gastroenterology and Hepatology 2006 4, 474-481DOI: (10.1016/j.cgh.2005.12.012) Copyright © 2006 American Gastroenterological Association Terms and Conditions

Figure 2 Comparisons of IBS-QOL scores between IBS and IBD patients. No significant differences were seen for the total score but IBS patients had significantly greater disturbances on scales for body image and food avoidance. *P < .05. Clinical Gastroenterology and Hepatology 2006 4, 474-481DOI: (10.1016/j.cgh.2005.12.012) Copyright © 2006 American Gastroenterological Association Terms and Conditions

Figure 3 Proportionate use of coping strategies. Compared with controls, IBD and IBS patients endorsed significantly more escape avoidance and accepting responsibility items (ANOVA). IBD and IBS patients also endorsed significantly fewer items pertaining to planful problem solving and positive reappraisal. *P < .05 by ANOVA; #P < .05 vs control by post-test comparison vs control. Clinical Gastroenterology and Hepatology 2006 4, 474-481DOI: (10.1016/j.cgh.2005.12.012) Copyright © 2006 American Gastroenterological Association Terms and Conditions